Albertine Donker

Chapter 1 42 90. Pietrangelo A. Pathogens, Metabolic Adaptation, and Human Diseases--An Iron- Thrifty Genetic Model. Gastroenterology. 2015;149(4):834-838. 91. Georgieff MK. Iron assessment to protect the developing brain. The American journal of clinical nutrition. 2017;106(Suppl 6):1588s-1593s. 92. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nature genetics. 2014;46(7):678-684. 93. Renassia C, Peyssonnaux C. New insights into the links between hypoxia and iron homeostasis. Current opinion in hematology. 2019. 94. Camaschella C. Iron and hepcidin: a story of recycling and balance. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2013;2013:1-8. 95. Camaschella C. Iron-Deficiency Anemia. The New England journal of medicine. 2015;373(5):485-486. 96. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochimica et biophysica acta. 2012;1823(9):1434-1443. 97. Deugnier Y, Turlin B. Pathology of hepatic iron overload. Seminars in liver disease. 2011;31(3):260-271. 98. Origa R, Cazzola M, Mereu E, et al. Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and beta- thalassemia intermedia. Haematologica. 2015;100(5):e169-171. 99. Pippard MJ, Weatherall DJ. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias. Haematologia. 1984;17(1):17-24. 100. Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019;133(1):40-50. 101. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public health nutrition. 2009;12(4):444-454. 102. Camaschella C. New insights into iron deficiency and iron deficiency anemia. Blood reviews. 2017. 103. Lopez A, Cacoub P, Macdougall IC, Peyrin- Biroulet L. Iron deficiency anaemia. Lancet. 2015. 104. Lozoff B, Jimenez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. New England journal of medicine. 1991;325(10):687-694. 105. Yadav D, Chandra J. Iron deficiency: beyond anemia. Indian journal of pediatrics. 2011;78(1):65-72. 106. Agarwal R. Nonhematological benefits of iron. American journal of nephrology. 2007;27(6):565-571. 107. Silvestri L, Guillem F, Pagani A, et al. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. Blood. 2009;113(22):5605-5608. 108. De Falco L, Sanchez M, Silvestri L, et al. Iron refractory iron deficiency anemia. Haematologica. 2013;98(6):845-853. 109. Cui Y, Wu Q, Zhou Y. Iron-refractory iron deficiency anemia: new molecular mechanisms. Kidney international. 2009;76(11):1137-1141. 110. Melis MA, Cau M, Congiu R, et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron. Haematologica. 2008;93(10):1473-1479. 111. van der Harst P, Zhang W, Mateo Leach I, et al. Seventy-five genetic loci influencing the human red blood cell. Nature. 2012;492(7429):369-375. 112. Benyamin B, Esko T, Ried JS, et al. Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. Nature communications. 2014;5:4926. 113. Nai A, Pagani A, Silvestri L, et al. TMPRSS6